Cargando…
Predictors Of Seroconversion Following COVID-19 Vaccination
Autores principales: | Chiarella, Sergio, Jenkins, Sarah, Smith, Carin, Ahluwalia, Vaibhav, Prasad, Vikas, Iyer, Vivek, Theel, Elitza, Joshi, Avni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804390/ http://dx.doi.org/10.1016/j.jaci.2021.12.341 |
Ejemplares similares
-
Predictors of seroconversion after coronavirus disease 2019 vaccination
por: Chiarella, Sergio E., et al.
Publicado: (2022) -
Clinical characteristics of subjects with lack of seroconversion following COVID-19 vaccination
por: Ahluwalia, Vaibhav, et al.
Publicado: (2022) -
Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency
por: Squire, Jacqueline, et al.
Publicado: (2021) -
Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products
por: Manian, Deepti Vellaichamy, et al.
Publicado: (2021) -
Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review
por: Theel, Elitza S.
Publicado: (2022)